Basic Information
LncRNA/CircRNA Name | RP11-480I12.5 |
Synonyms | NA |
Region | NA |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | cervical cancer |
ICD-0-3 | C53 |
Methods | RT-qPCR, Western blotting |
Sample | CC tissues,cervical epithelial ECT cell line PCS-480-011, and the human CC cell lines SiHa (HTB-35), HeLa229 (CCL-2.1) and MS751 (HTB-34),C33A (HTB-31), HeLa (CCL-2) and Caski (CRM-CRL-1550) |
Expression Pattern | up-regulated |
Function Description | RP11-480I12.5 was upregulated in CC tissue compared with normal tissue. Furthermore, RP11-480I12.5 was associated with clinical stage, tumor size and lymph node metastasis. RP11-480I12.5 promoted the proliferation, migration and invasion of CC cell lines.RP11-480I12.5 promoted EMT through the Wnt/?-catenin pathway. |
Pubmed ID | 31897160 |
Year | 2020 |
Title | Long Non-Coding RNA RP11-480I12.5 Promotes Cervical Carcinoma Progression by Regulating the Wnt/?-catenin Signaling Pathway |
External Links
Links for RP11-480I12.5 | GenBank HGNC NONCODE |
Links for cervical cancer | OMIM COSMIC |